Blog - Titan Group

September 14, 2026

The First 90 Days: An EMS Agency DEA Compliance Checklist

Receiving a DEA registration is a major milestone for an EMS agency, but the work doesn't stop once the certificate arrives. The first 90 days are an essential opportunity to... Read More

September 9, 2026

Do You Know Why You Should Know Your Customers?

The concept of “know your customer” (KYC) is fundamental to successful prevention of diversion. And while it may seem simple in concept, there are aspects to this practice... Read More

August 10, 2026

The Risks of Voluntary DEA Registration Surrender: What to Know

You’ve made it through your DEA inspection. Paperwork was in order. You don’t think there are any major issues. The Diversion Investigator seems pleasant and reasonable. Even... Read More

August 10, 2026

How to Choose DEA Training for Busy Clinicians in 2026

Key Takeaways: How to Choose DEA Training for Busy Clinicians in 2026 The MATE Act requires an 8-hour, one-time training attestation for DEA registration renewal or initial... Read More

July 14, 2026

Marijuana Mess: Moving to Schedule III and Compliance Chaos

For years, the cannabis industry has waited for federal reform. The recent move reclassifying medical cannabis from Schedule I to Schedule III under the Controlled Substances... Read More

June 10, 2026

Power of Attorney: What It Is, Why It Matters, and How Veterinarians Get It Wrong

A Power of Attorney (POA) is one of the simplest — yet most commonly mishandled — documents in veterinary DEA compliance. When used properly, a POA allows a veterinarian who... Read More

May 26, 2026

Protecting Your Pharmacy from DEA Risk and Distributor Cut-Off

The compliance landscape for independent pharmacies has changed—and it’s getting tougher. Ongoing opioid litigation, enforcement actions, and increased scrutiny from the DEA... Read More

May 18, 2026

What DEA Manufacturing License Holders Must Know About Drug Diversion

Supply Chain Drug Diversion Prevention: What DEA Manufacturing License Holders Must Know The diversion of drugs remains one of the most serious risks within pharmaceutical... Read More

May 15, 2026

Blind Spots in Plain Sight: The Value of an Unbiased Compliance Review

How TITAN’s Third-Party Audits Help Facilities Stay Ahead An organization’s approach to regulatory compliance is often shaped by familiarity. Processes evolve, workarounds... Read More

May 11, 2026

Vets’ Biennial Inventory Blunders —And How to Avoid Them

TITAN Group’s DEA compliance experts – former DEA Diversion Investigators – saw countless violations of the Controlled Substance Act (CSA) during their many years of... Read More

May 11, 2026

The Drug Supply Chain Security Act Explained: What Pharmacies and Manufacturers Must Know

The pharmaceutical supply chain is under increasing scrutiny as regulators and industry leaders work to combat counterfeit drugs, diversion, and other vulnerabilities that... Read More

May 4, 2026

Medetomidine: What Pharmacies Must Do Now

Medetomidine: The Next Dangerous Threat in the Illicit Drug Supply & What Pharmacies Must Do Now The opioid crisis continues to evolve in ways that make it increasingly... Read More

March 10, 2026

The New DEA Reality for EMS: What Changed on March 9, 2026 — and What It Means for Your Agency

Effective March 9, 2026, EMS agencies officially became DEA registrants. Read More

March 6, 2026

Theft and Significant Loss of Controlled Substances - Understanding Federal and State Reporting Requirements

Controlled substances are tightly regulated because they carry a high potential for abuse, diversion, and misuse. When a theft or significant loss occurs, the risk to public... Read More